For best viewing results, please view this email in HTML.
December 16, 2015
“Fate helps those who are willing. It drags those who are not.”
–Roman Proverb
The Scope appreciates the enthusiastic response of readers contributing quotes. This quote
was submitted by Erich J. Bohrmann, PA-C. Please submit a favorite you’d like to share with
others by emailing to: [email protected]
Dear Members of the Maine Medical Center Medical Staff,
In this issue, you will see that MaineHealth has announced a partnership with Boston’s
Dana-Farber Cancer Institute. Under this new relationship, according to Dr. Scot Remick
and Barbara Grillo, cancer patients at the 11 MaineHealth members or affiliated hospitals
will have streamlined access to Dana-Farber in Boston for complex specialty care and
clinical trials. And Dana-Farber will provide consultation, training, and other services to
physicians and their teams throughout the MaineHealth system.
Dr. Randy Darby has details on the new medical team training facility officially opening in
January on the Bramhall campus, and Dr. Mark Parker announces that also next month the
Division of Nephrology and Transplantation will introduce a new advanced practice
provider (APP) component to MMC inpatient nephrology consultation services.
And finally, as many of you know – we are making a transition in the MMC Chief Medical
Officer role. In the New Year, Dr. Joel Botler will lead in this role as Interim CMO. We have
been collaborating on a smooth hand-off and Joel is an excellent choice to lead this
transition.
We wish you all have a very happy and healthy holiday season.
Peter Bates, MD
Chief Medical Officer
Cindy Boyack, MD
Medical Staff President
In This Issue
MMC CMO Transition Announced
MaineHealth to Partner with Dana-Farber Cancer Institute
A Good Move: Making Room for Team Training at Bramhall
Nephrology APP Patient Inservice
Publications
Calendar
MMC CMO Transition Announced
By Peter Bates, M.D.
As many of you know, I’m making a transition in my professional role to become MMC’s
Chief Academic Officer on January 4, 2016. In doing so, I will relinquish my responsibilities
as Chief Medical Officer after nearly eight years in that post. I have worked closely with
Rich Petersen and the Board of Trustees on a plan to ensure a smooth transition and I am
grateful to them for the privilege of serving as CMO and the trust they and you have in me
to be MMC’s first CAO.
In the past several years, I have had the pleasure of working with you on many initiatives
spanning our mission realms of patient care, education and research. Whether we have
been responding to challenges or seeking opportunities, it has been an enjoyable and
fulfilling experience for me. Many of these projects have led to lasting improvements in
our organization and the care we provide to our community – it doesn’t get any better than
that. Thank you for making my role as CMO so fulfilling.
I also want to thank all of you for making MMC such a unique and special place. I have
worked with many of you in many different capacities for years, and in some cases,
decades. Whether at the bedside or in the boardroom; Noontime or at 2 a.m. on a Sunday,
people who work at MMC come together and place patients first. Like many of you, I have
friends and colleagues in health care across the country and few of them feel the same
about their organization. We are all very fortunate.
In my new role as CAO, I’m looking forward to continuing to work with you to build our
future in education and research. We have accomplished a great deal and yet there is so
much need and opportunity. Our responsibility is to not only educate and train the best
clinicians, but also to ensure that in doing so we help make health and health care better in
the State of Maine. I am very excited and energized by the possibilities.
An important part of any transition is succession. Joel Botler is an excellent choice for
Interim CMO, someone I have known for many years and for whom I have the highest
respect. We have been collaborating on a smooth hand-off and I know that our
organization will be well led by Joel.
Finally, I want to thank you for your support, understanding, mentoring, collegiality and
friendship. For organizations to be successful it all comes down to the people who share a
common vision, values and commitment. I am humbled by the opportunities I have
received and inspired by the people with whom I am privileged to work.
Back to Top
MaineHealth to Partner with Dana-Farber Cancer Institute
By Scot Remick, M.D., MaineHealth/MMC Physician Leader of Oncology
Barbara Grillo, Vice President, MaineHealth/MMC Oncology Service Line
MaineHealth has announced a partnership with Boston’s Dana-Farber Cancer Institute to
provide residents of Maine and eastern New Hampshire with the best cancer care possible.
Under this new relationship, cancer patients at the 11 MaineHealth member and affiliated
hospitals will have streamlined access to Dana-Farber in Boston for complex specialty care
and clinical trials, and Dana-Farber will provide consultation, training, and other services to
physicians and their teams throughout the MaineHealth system.
Since 2013, the MaineHealth Oncology Leadership Council has been working with the 11
member and affiliate hospitals to develop a system-wide approach to cancer care that will
enable patients to receive quality care as close to home as possible. The partnership with
Dana-Farber provides the support of one of the world’s leading centers of cancer treatment
and research that is designated a comprehensive cancer center by the National Cancer
Institute. MaineHealth and Dana-Farber will work together to expand or develop a wide
range of survivorship, second-opinion, education, and personalized medicine initiatives
offered by MaineHealth.
In their joint announcement, Bill Caron, president of MaineHealth, and Edward J. Benz, Jr.,
M.D., president of Dana-Farber Cancer Institute, praised the partnership, which will create
an unprecedented range of options for cancer patients throughout the region.
Specifically, Dana-Farber will:
Advise and consult on development and enhancement of value based oncology care
programs such as
 survivorship care,
 enhanced navigation programs, and
 cancer registry data management.
Provide research collaboration, including
 direct access for patients in early phase clinical trials, enabling some aspects to be
handled locally within the MaineHealth network;
 participation in the Dana-Farber Cancer Institute Profile study and other
personalized medicine initiatives; and
 joint grant applications for oncology-related medical research.
Develop medical education, including determining the potential for
 a fellowship program and
 enhanced education opportunities for allied health professionals here.
For more information, contact Scot Remick, [email protected], or Barbara Grillo,
[email protected].
Back to Top
A Good Move: Making Room for Team Training at Bramhall
By J. Randy Darby, MD, Medical Director, Hannaford Center for Safety, Innovation and
Simulation
In January, MMC will officially open a new medical team training facility at its Bramhall
campus. It took a team effort for this new space to come together including collaboration
between employees in R3, Surgery and Simulation, and two years of planning by the
Facilities team to transform the 80- year-old Pavilion 3A area into an innovative team
training facility.
The new 1,600 sq. ft. site is a satellite location to the 18,000 sq. ft. Hannaford Center for
Safety, Innovation and Simulation located at MMC’s Brighton Campus, which has hosted
training for more than 25,000 medical professionals since it opened in 2010.
At the Bramhall campus, people and spaces were relocated throughout MMC in a series of
at least 10 moves. The result of everyone’s efforts is a new satellite location that enables
interdisciplinary medical teams to train together on a routine basis to repetitively practice
critical events, where rapid delivery of high-quality care makes a difference in patient
outcomes.
The facility will have a patient room, where medical teams including, residents, nurses and
therapists can practice actual emergency situations. The training facility will be outfitted
with an adult and pediatric patient simulator. These simulators will be used for emergency
training exercises such as Code Blues (Adult and Pediatric), stroke and DART (Difficult
Airway Response Team).
It also includes a skills lab, where surgeons can prepare for the use of robotics technologies.
The surgical skills room will accommodate three work stations outfitted with virtual
trainers. The da Vinci robotic simulator, Heartworks TEE and TTE simulator and the
Simbionix Bronchoscopy and Colonoscopy trainer are all located in the skills room.
If you would like more information please contact me at 662-7060, or Kim Bassett at 6624984.
Making room, by the numbers:

Skills Lab (300 sq. ft.)
o Space for various robotic training equipment

Simulation Patient room (230 sq. ft.)
o Team training room

Simulation control room (80 sq. ft.)

Debrief Room (212 sq. ft.)
o Review of training exercise

Conference Room (300 sq. ft.)

Provider Workroom 1 (220 sq. ft.)

Provider Workroom 2 (200 sq. ft.)
Back to Top
Nephrology APP Patient Inservice
By Mark Parker, MD
MMC Director of the Division of Nephrology and Transplantation
The Division of Nephrology and Transplantation will introduce a new advanced practice
provider (APP) component to MMC inpatient nephrology consultation services, beginning
in January, 2016. Four APP’s from Maine Nephrology Associates (MNA) will be rotating
members of the consult service.
A substantial proportion of consult service patients will continue to be seen by the teaching
team, including the service attending, nephrology fellows, residents and students.
However, APP’s also will perform new patient consultations in conjunction with the service
attending staff and provide independent follow up of a cohort of 8-12 patients each day.
APP’s will take call with nephrology attending staff as well. The additional providers are
anticipated to augment the ability of the nephrology division to provide timely and
comprehensive nephrology consultative care as well as enhance the educational
experience for learners on the nephrology teaching team.
The MNA nephrology APP’s will bring strong background experience in outpatient chronic
kidney disease and end stage renal disease care to this endeavor. One member, Mike
Tranfaglia, PA-C, will be a familiar face to many, as he has additional previous experience as
a Vascular Surgery inpatient provider at MMC, and as a voting member of the MMC
Credentials Committee. Eric Holmes, PA-C, will also begin on the inpatient nephrology
consult service in January. Emily Snow, FNP, and Sara Rosa, PA-C, will join the consult
service soon after completing the privileging process.
Deborah Hoch, NP, of the Maine Transplant Program and the recent recipient of the 2016
AANP Maine State Award for Excellence will continue to provide care on the inpatient
transplantation service.
Back to Top
Publications
Siegel M, Smith KA, Mazefsky C, Gabriels RL, Erickson C, Kaplan D, Morrow EM, Wink L,
Santangelo SL; Autism and Developmental Disorders Inpatient Research Collaborative
(ADDIRC). The autism inpatient collection: methods and preliminary sample description.
Mol Autism. 2015 Nov 10;6:61.
Xi G, Rosen CJ, Clemmons DR. IGF-I and IGFBP-2 stimulate AMPK activation and autophagy
which are required for osteoblast differentiation. Endocrinology. 2015 Nov 10:en20151690.
Brownell AD, Reynolds TQ, Livingston B, McCarthy CA. Human parechovirus-3 encephalitis
in two neonates: acute and follow-up magnetic resonance imaging and evaluation of
central nervous system markers of inflammation. Pediatr Neurol. 2015 Feb;52(2):245-9
Badrinath R, Kakembo N, Kisa P, Langer M, Ozgediz D, Sekabira J. Outcomes and unmet
need for neonatal surgery in a resource-limited environment: estimates of global health
disparities from Kampala, Uganda. J Pediatr Surg. 2014 Dec;49(12):1825-30.
Waksman R, Kirtane AJ, Torguson R, Cohen DJ, Ryan T, Räber L, Applegate R, Waxman S,
Gordon P, Kaneshige K, Leon MB; DESERT Investigators. Correlates and outcomes of late
and very late drug-eluting stent thrombosis: results from DESERT (International DrugEluting Stent Event Registry of Thrombosis). JACC Cardiovasc Interv. 2014 Oct;7(10):1093102.
Lin N, Lanzino G, Lopes DK, Arthur AS, Ogilvy CS, Ecker RD, Dumont TM, Turner RD 4th,
Gooch MR, Boulos AS, Kan P, Snyder KV, Levy EI, Siddiqui AH. Treatment of Distal Anterior
Circulation Aneurysms With the Pipeline Embolization Device: A US Multicenter Experience.
Neurosurgery. 2015 Nov 16
Hardouin P, Marie PJ, Rosen CJ. New Insights into Bone Marrow Adipocytes: Report from
the First European Meeting on Bone Marrow Adiposity (BMA 2015). Bone. 2015 Nov 19.
Yeh LJ, Shively NR, Isacke RN, Dowling CA, Stogsdill PB. Miliary tuberculosis characterised
by lipomembranous fat necrosis. Lancet Infect Dis. 2015 Dec;15(12):1497.
Ingelfinger JR, Rosen CJ. Cardiovascular Risk and Sodium-Glucose Cotransporter 2 Inhibition
in Type 2 Diabetes. N Engl J Med. 2015 Nov 26;373(22):2178-9.
Hoffman RM, Elmore JG, Pignone MP, Gerstein BS, Levin CA, Fairfield KM. Knowledge and
values for cancer screening decisions: Results from a national survey. Patient Educ Couns.
2015 Nov 10.
McGuire K, Erickson C, Gabriels RL, Kaplan D, Mazefsky C, McGonigle J, Meservy J, Pedapati
E, Pierri J, Wink L, Siegel M. Psychiatric Hospitalization of Children With Autism or
Intellectual Disability: Consensus Statements on Best Practices. J Am Acad Child Adolesc
Psychiatry. 2015 Dec;54(12):969-71.
Sammon JD, Dalela D, Abdollah F, Choueiri TK, Han PK, Hansen M, Nguyen PL, Sood A,
Menon M, Trinh QD. Determinants of Prostate Specific Antigen Screening Among Black
Men in the United States in the Contemporary Era. J Urol. 2015 Nov 17.
Karol SE, Mattano LA Jr, Yang W, Maloney KW, Smith C, Liu C, Ramsey LB, Fernandez CA,
Chang TY, Neale G, Cheng C, Mardis E, Fulton R, Scheet P, San Lucas FA, Larsen EC, Loh ML,
Raetz EA, Hunger SP, Devidas M, Relling MV. Genetic risk factors for the development of
osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia. Blood.
2015 Nov 20
Judith A. Vessey, PhD, RN, FAAN, Tania D. Strout, PhD, RN, MS, Rachel DiFazio, PhD, RN,
FAAN, Allison Walker. Measuring the Youth Bullying Experience: A Systematic Review of the
Psychometric Properties of Available Instruments. Journal of School Health. 2014; 84: 819843.
Sara Nelson, MD, Heather Hammerstedt, MD, MPH*; Samuel Maling, MBChB; Ronald
Kasyaba, MBChB; Bradley Dreifuss, MD; Stacey Chamberlain, MD, MPH; Mark Bisanzo, MD,
DTM&H. Addressing World Health Assembly Resolution 60.22: A Pilot Project to Create
Access to Acute Care Services in Uganda. Annals of Emergency Medicine. 2014; 64(5): 461468.
Back to Top
Calendar
MMC Medical Executive Committee Meeting Schedule for 2015
All meetings are held from 12-2 p.m. in the Dana Center Boardroom, and lunch will be
served:

Friday, December 18
2016 Medical Staff Dinner
Please mark your calendar for the 2016 Medical Staff Dinners:


April 6, 2016
September 28, 2016
Back to Top
Story Ideas?
Your participation is essential to making The Scope a dynamic and sustainable publication.
Please submit articles of 250-300 words to [email protected]. Include practitioner’s
byline with title and appropriate contact for further information. We publish two times
each month.
To view past issues, visit www.mmc.org/TheScope.
Back to Top
Medical Staff Value, Mission, and Vision Statements
Value Statement
The Medical Staff of Maine Medical Center values both individuality and collaboration. We
will continually pursue higher value health care. We embrace a culture of curiosity and lifelong learning. We are partners with Maine Medical Center, and we mirror its values of
compassion, service, integrity, respect, and stewardship.
Mission Statement
The Mission of the Medical Staff of Maine Medical Center is to provide affordable, highquality health care to our community. We teach future health care providers and develop
innovative ways to improve the health of our community. In partnership with the Medical
Center, we proudly accept our responsibility as one of Maine’s leaders in patient care,
education, and research.
Vision Statement
The Medical Staff of Maine Medical Center will be the driving force within Maine Medical
Center leading the way to making Maine the healthiest state in the nation.
A Compact Between Maine Medical Center and Its Medical Staff
Peer Support
for the MMC Medical Staff
[email protected]
Physician leader: Christine Irish, MD
Confidential * One-on-One * Peer Support
Back to Top
www.mmc.org
22 Bramhall Street, Portland, ME 04102 | (207) 662-0111
Please do not reply to this message; reply only to the phone number or email address listed.